Detecting ovarian cancer in primary care: can we do better?

Affiliations

¹ Primary Care Unit, Department of Public Health and Primary care, University of Cambridge, Cambridge.
² Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester, Manchester.
³ University of Exeter Medical School, University of Exeter, Exeter.
⁴ Wolfson Institute of Population Health, Faculty of Medicine & Dentistry, Queen Mary University of London, London.

Editorial

Garth Funston et al. Br J Gen Pract. 2022.

. 2022 Jun 30;72(720):312-313.

doi: 10.3399/bjgp22X719825. Print 2022 Jul.

¹ Primary Care Unit, Department of Public Health and Primary care, University of Cambridge, Cambridge.
² Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester, Manchester.
³ University of Exeter Medical School, University of Exeter, Exeter.
⁴ Wolfson Institute of Population Health, Faculty of Medicine & Dentistry, Queen Mary University of London, London.

No abstract available

Figures

1. NHS England . The NHS Long Term Plan. London: NHS England; 2019.
1. Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182–2193. - PMC - PubMed
1. Cancer Research UK (CRUK) Ovarian cancer incidence statistics. London: CRUK;
1. CRUK . Ovarian cancer survival statistics. London: CRUK;
1. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705–2712. - PubMed